Prelude Therapeutics Incorporated Share Price
PRLDPrelude Therapeutics Incorporated Stock Performance
Open $2.52 | Prev. Close $2.59 | Circuit Range N/A |
Day Range $2.45 - $2.63 | Year Range $0.61 - $4.18 | Volume 13,700 |
Average Traded $2.56 |
Prelude Therapeutics Incorporated Share Price Chart
About Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Prelude Therapeutics Incorporated Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $2.52 | $2.56 | +0.00% |
06-Jan-26 | $2.52 | $2.56 | +4.92% |
05-Jan-26 | $2.65 | $2.44 | -12.07% |
02-Jan-26 | $2.80 | $2.77 | -3.98% |
31-Dec-25 | $2.78 | $2.89 | +1.76% |
30-Dec-25 | $2.81 | $2.84 | -3.40% |
29-Dec-25 | $2.41 | $2.94 | +20.00% |
FAQs on Prelude Therapeutics Incorporated Share Price
Can I buy Prelude Therapeutics Incorporated shares in India?
What is the share price of Prelude Therapeutics Incorporated?
What is the 5 year returns of Prelude Therapeutics Incorporated?
What are the high & low stock price of Prelude Therapeutics Incorporated today?
What is the 52-week high and low of Prelude Therapeutics Incorporated stock?